Failure by the manufacturer, importer or distributor of a raw material for pharmaceutical use to communicate to the Agence nationale de sécurité du médicament et des produits de santé any changes to the information or particulars contained in the documents requested for authorisation or in the declaration or descriptive dossier provided for in Article L. 5138-1, in accordance with the conditions laid down in Articles R. 5138-1 and R. 5138-2, shall be punishable by a fine of the 4th class.